Latest Articles

Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.

It’s the journey, not just the destination that counts as a scientist when conducting research.

At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).

Faced with increasing challenges such as costly treatments and treatments that are palliative rather than symptomatic, the global healthcare industry today is gradually transforming itself.

Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.

Understand current trends and learn which application areas are expected to gain in popularity over the next few years.

With 60% of women diagnosed with ovarian cancer dying within five years of diagnosis there has been considerable efforts to try to detect the disease at an earlier stage.

The Wyss Institute for Biologically Inspired Engineering has created a channel on Labtube.

Select Biosciences, organizers of European Lab Automation (ELA) 2011, announces that the World Biobanking Summit will join the highly topical conference streams already confirmed at this unique laboratory automation conference and exhibition.